Header Logo

Connection

Naoko Takebe to Plasmacytoma

Back to Details
This is a "connection" page, showing publications Naoko Takebe has written about Plasmacytoma.
Naoko Takebe
Connection Strength
0.060
Plasmacytoma
  1. Phase I clinical trial of the inosine monophosphate dehydrogenase inhibitor mycophenolate mofetil (cellcept) in advanced multiple myeloma patients. Clin Cancer Res. 2004 Dec 15; 10(24):8301-8.
    View in: PubMed
    Score: 0.060
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.